Streblow DN - Search Results

1

Rat cytomegalovirus-accelerated transplant vascular sclerosis is reduced with mutation of the chemokine-receptor R33.

Streblow DN, Kreklywich CN, Smith P, Soule JL, Meyer C, Yin M, Beisser P, Vink C, Nelson JA, Orloff SL. Streblow DN, et al. Am J Transplant. 2005 Mar;5(3):436-42. doi: 10.1111/j.1600-6143.2004.00711.x. Am J Transplant. 2005. PMID: 15707397 Free article.

2

The human cytomegalovirus chemokine receptor US28 mediates vascular smooth muscle cell migration.

Streblow DN, Soderberg-Naucler C, Vieira J, Smith P, Wakabayashi E, Ruchti F, Mattison K, Altschuler Y, Nelson JA. Streblow DN, et al. Cell. 1999 Nov 24;99(5):511-20. doi: 10.1016/s0092-8674(00)81539-1. Cell. 1999. PMID: 10589679 Free article.

3

The human cytomegalovirus IE86 protein can block cell cycle progression after inducing transition into the S phase of permissive cells.

Murphy EA, Streblow DN, Nelson JA, Stinski MF. Murphy EA, et al. Among authors: streblow dn. J Virol. 2000 Aug;74(15):7108-18. doi: 10.1128/jvi.74.15.7108-7118.2000. J Virol. 2000. PMID: 10888651 Free PMC article.

4

Kinetics and development of CMV-accelerated transplant vascular sclerosis in rat cardiac allografts is linked to early increase in chemokine expression and presence of virus.

De La Melena VT, Kreklywich CN, Streblow DN, Yin Q, Cook JW, Soderberg-Naucler C, Bruggeman CA, Nelson JA, Orloff SL. De La Melena VT, et al. Among authors: streblow dn. Transplant Proc. 2001 Feb-Mar;33(1-2):1822-3. doi: 10.1016/s0041-1345(00)02729-9. Transplant Proc. 2001. PMID: 11267529 No abstract available.

5

Reactivation of latent human cytomegalovirus in CD14(+) monocytes is differentiation dependent.

Söderberg-Nauclér C, Streblow DN, Fish KN, Allan-Yorke J, Smith PP, Nelson JA. Söderberg-Nauclér C, et al. Among authors: streblow dn. J Virol. 2001 Aug;75(16):7543-54. doi: 10.1128/JVI.75.16.7543-7554.2001. J Virol. 2001. PMID: 11462026 Free PMC article.

6

Do pathogens accelerate atherosclerosis?

Streblow DN, Orloff SL, Nelson JA. Streblow DN, et al. J Nutr. 2001 Oct;131(10):2798S-2804S. doi: 10.1093/jn/131.10.2798S. J Nutr. 2001. PMID: 11584110 Review.

7

Elimination of donor-specific alloreactivity prevents cytomegalovirus-accelerated chronic rejection in rat small bowel and heart transplants.

Orloff SL, Streblow DN, Soderberg-Naucler C, Yin Q, Kreklywich C, Corless CL, Smith PA, Loomis CB, Mills LK, Cook JW, Bruggeman CA, Nelson JA, Wagner CR. Orloff SL, et al. Among authors: streblow dn. Transplantation. 2002 Mar 15;73(5):679-88. doi: 10.1097/00007890-200203150-00005. Transplantation. 2002. PMID: 11907411

8

Retrieval of human cytomegalovirus glycoprotein B from cell surface is not required for virus envelopment in astrocytoma cells.

Jarvis MA, Fish KN, Söderberg-Naucler C, Streblow DN, Meyers HL, Thomas G, Nelson JA. Jarvis MA, et al. Among authors: streblow dn. J Virol. 2002 May;76(10):5147-55. doi: 10.1128/jvi.76.10.5147-5155.2002. J Virol. 2002. PMID: 11967330 Free PMC article.

9

Infection of APC by human cytomegalovirus controlled through recognition of endogenous nuclear immediate early protein 1 by specific CD4(+) T lymphocytes.

Le Roy E, Baron M, Faigle W, Clément D, Lewinsohn DM, Streblow DN, Nelson JA, Amigorena S, Davignon JL. Le Roy E, et al. Among authors: streblow dn. J Immunol. 2002 Aug 1;169(3):1293-301. doi: 10.4049/jimmunol.169.3.1293. J Immunol. 2002. PMID: 12133951

10

The HCMV chemokine receptor US28 is a potential target in vascular disease.

Streblow DN, Orloff SL, Nelson JA. Streblow DN, et al. Curr Drug Targets Infect Disord. 2001 Aug;1(2):151-8. doi: 10.2174/1568005014606080. Curr Drug Targets Infect Disord. 2001. PMID: 12455411 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

124 results

Search Page

Filters